Innovative Medical Device Extends Possibility of Minimally Invasive Endovascular Repair of Aortic Aneurysms to More Patients
Products
Smith & Nephew wins price cut in Plus
Smith & Nephew on Thursday said it had won a SFr159m ($141m, £109m) cut in the purchase price of Plus Orthopedics, the business which caused it to issue a shock profit warning in May last year.
Flexible Stenting Solutions, Inc. Receives CE Mark for New FlexStent™ Femoropopliteal Self Expanding Stent System
Flexible Stenting Solutions, Inc., a leading developer of next-generation flexible stents, announced today it has received CE Mark for its FlexStent™ Femoropopliteal Self Expanding Stent System.
Entegrion Welcomes Peter C. Johnson, MD as Executive Vice President and Chief Business Officer
Life sciences company Entegrion continues to strengthen its leadership team with the addition of Peter C. Johnson, MD, who will serve as Executive Vice President and Chief Business Officer, effective
immediately.
Adhezion Biomedical Announces CE Mark Approval for Film-Forming Microbial Sealant Floraseal
Adhezion Biomedical LLC announced today that it received European CE Mark (Conformité Européene) approval for FloraSeal, a film-forming, cyanoacrylate-based microbial sealant in a ready-to-use applicator.
ArthroCare Obtains a Waiver of Default under Its Credit Agreement
ArthroCare Corp. announced that it received a waiver today from the Lenders and the Administrative Agent under its Credit Agreement of the event of default relating to the delisting of the Company’s stock.
St. Jude Medical Announces Publication of 20-year Durability in Aortic and Mitral Stented Tissue Valves
Study reports excellent long-term durability of the St. Jude Medical Biocor Stented Tissue Valve for mitral and aortic valve replacement
CUREXO Technology Corporation Names Brent D. Mittelstadt as President & CEO
CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, announced the addition of Brent D. Mittelstadt to its senior management team as President and Chief Executive Officer.
ArthroCare Receives Nasdaq Delisting Notice
ArthroCare Corp. announced today that it received a letter from the Nasdaq Listing Qualifications Panel, dated January 14, 2009, stating that the Panel has determined to suspend and delist trading of the Company’s common stock on The Nasdaq Stock Market.
Orthomimetics Secures CE Mark Approval for Chondromimetic
Orthomimetics Limited, the UK-Based Regenerative Medicine Company, has Received CE Mark Approval for Chondromimetic, its Flagship Product for the Repair of Articular Cartilage and Bone
Facet replacement technology becomes a reality
Archus Orthopedics, Inc. announced the first human use of its facet replacement technology.
Biomet Announces Financial Results for Second Quarter of Fiscal Year 2009
Biomet, Inc. announced today financial results for its second fiscal quarter ended November 30, 2008.
Allium Group Receives CE Mark for Its Next-Generation Prostatic Stent
Allium Group announced today that it has been awarded CE mark for its prostatic stent enabling commercialization of the system in the European Union and the countries that recognize the CE Mark.
DiFUSION Technologies Announces Company Launch Focused on Surgical Site Infections (SSIs)
DiFUSION to mitigate SSIs that affect an estimated 780,000 patients in the United States each year
Medtronic Launches Its First Integrated Power Console (IPC™) Platform for Use in Spinal, Cranial, and Ear, Nose, and Throat Surgeries
Medtronic, Inc. (NYSE: MDT) has announced the launch of the Integrated Power Console (IPC™) platform, its first multispecialty surgical power console for use in spinal, cranial, and ear, nose, and throat (ENT) surgeries
Stryker barred from selling medical screw-appeals court
WASHINGTON, Dec 30 (Reuters) – A U.S. appeals court upheld an order on Tuesday barring medical device maker Stryker Corp (SYK.N) from selling a screw to fix broken bones because it infringes a patent held by Acumed LLC